Scientists Identify Druggable Target in Schizophrenia CNV

February 4, 2011

February 4, 2011 | Scientists at UCSD have identified a copy number variant in 1 in 300 schizophrenia patients that contains the gene for a known neuropeptide receptor called VIPR2, presenting a highly druggable target against the disorder. The results are reported in this week's issue of NatureMedscape